These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3264023)

  • 1. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major.
    Moll H; Mitchell GF
    J Parasitol; 1988 Dec; 74(6):993-8. PubMed ID: 3264023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C; Schröppel K; Lohoff M; Röllinghoff M; Solbach W
    Eur J Immunol; 1990 Dec; 20(12):2533-40. PubMed ID: 1980108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
    Mitchell GF
    J Immunogenet; 1983 Oct; 10(5):395-412. PubMed ID: 6606002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG; Lima GC; Engers HD; Louis JA
    J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for gamma delta + T cells during experimental infection of mice with Leishmania major.
    Rosat JP; MacDonald HR; Louis JA
    J Immunol; 1993 Jan; 150(2):550-5. PubMed ID: 8419488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M; Finbloom DS; Van Der Meide PH; Slayter MV; Nacy CA
    J Immunol; 1989 Jul; 143(1):266-74. PubMed ID: 2499629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
    J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic immunization against experimental leishmaniasis. VI. Comparison of protective and disease-promoting T cells.
    Liew FY; Hodson K; Lelchuk R
    J Immunol; 1987 Nov; 139(9):3112-7. PubMed ID: 3312413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed-type hypersensitivity.
    Titus RG; Müller I; Kimsey P; Cerny A; Behin R; Zinkernagel RM; Louis JA
    Eur J Immunol; 1991 Mar; 21(3):559-67. PubMed ID: 1672641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
    Holaday B; Sadick MD; Pearson RD
    J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.
    Sunderkötter C; Kunz M; Steinbrink K; Meinardus-Hager G; Goebeler M; Bildau H; Sorg C
    J Immunol; 1993 Nov; 151(9):4891-901. PubMed ID: 8409447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL; Scott PA; Asofsky R; Sher FA
    J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.
    Soong L; Chang CH; Sun J; Longley BJ; Ruddle NH; Flavell RA; McMahon-Pratt D
    J Immunol; 1997 Jun; 158(11):5374-83. PubMed ID: 9164958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY; Hale C; Howard JG
    J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.